Neuroone Medical Technologies (NMTC)Chief Business Officer bought ~$67K

~$67K

Approx. value · 33K sh @ $2.01

200K

Holds after · shares reported

Traded

Aug 27, 2026

Filed

Sep 8, 2026

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

1. Jun 30, 2026InsiderOfficer sold ~$32K of NMTC shares in the open market
2. Aug 13, 2026Company filing · Form 8-K · ResultsReported its results
3. Aug 27, 2026 · this disclosureInsiderOfficer purchased ~$67K of NMTC shares in the open market

What came next

1. Oct 5, 2026Company filing · Form 8-K · Results, Other newsReported its results, and reported other company news

How to read SEC Form 4

Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.

Full guide: What is an SEC Form 4?

What else is on file for Neuroone Medical Technologies

For Neuroone Medical Technologies, OQRO holds 1 insider filing (SEC Form 4 or Form 144) dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its NMTC page.

Other recent filings by David J. Wambeke, Chief Business Officer

• SEC Form 4 at Neuroone Medical Technologies (NMTC)Mar 3, 2026

The full history of David J. Wambeke, Chief Business Officer is on the profile page.

How this filing works

• SEC Form 4
• Open-market purchase
• Rule 10b5-1 trading plans

Other disclosures at Neuroone Medical Technologies

• SEC Form 4Jul 3, 2026
• SEC Form 4Apr 2, 2026
• SEC Form 4Mar 16, 2026
• SEC Form 4Mar 16, 2026
• SEC Form 4Mar 12, 2026
• SEC Form 4Mar 12, 2026

Everything OQRO holds on this company is on its NMTC page.